Epilepsy Research Challenges Traditional View of Positive Spikes in Children
Researchers at the State University of New York (SUNY) Buffalo have published a new study challenging the traditional view of positive spikes in children with Self-limited Epilepsy with Centrotemporal spikes. The study examined the prevalence and functional significance of 14 and 6 Hz positive spikes (PS) in 52 pediatric patients and 52 age-matched controls. The research found that 14 and 6 Hz PS were detected in 80.8% of SeLECTs patients, but not in controls. The study suggests that these spikes may play a role in thalamocortical dysregulation in self-limited childhood epilepsies, contradicting the traditional view that they are benign.
Key Takeaways:
- The study included 52 pediatric Self-limited Epilepsy with Centrotemporal spikes patients and 52 age-matched controls.
- 14 and 6 Hz PS were detected in 80.8% (n = 42) of SeLECTs patients versus 0% of controls (P < 0.001).
- The research suggests that 14 and 6 Hz PS may play a role in thalamocortical dysregulation in self-limited childhood epilepsies.
- The study challenges the traditional view of PS as benign and highlights the potential importance of these spikes in understanding epilepsy in children.
- The research was conducted at the epilepsy monitoring unit at Oishee Children's Hospital from 2016 to 2024.
- The study provides new insights into the pathophysiology of childhood epilepsy and has implications for the diagnosis and treatment of this condition.
Statistics:
- 80.8% (n = 42) of SeLECTs patients had 14 and 6 Hz PS detected, compared to 0% of controls.
- 52 pediatric Self-limited Epilepsy with Centrotemporal spikes patients and 52 age-matched controls participated in the study.
- 2016 to 2024 was the study period for the epilepsy monitoring unit at Oishee Children's Hospital.
Sources:
- "Prevalence and Functional Significance of 14 and 6 Hz Positive Spikes in Self-Limited Epilepsy With Centrotemporal Spikes: A Case-Control Study." Journal of Clinical Neurophysiology, 2025.
- Health & Medicine Week. NewsRx. October 31, 2025; p 587.